MHRA – Advertising and Promotion Guidance Following Agreement of the Windsor Framework The MHRA has issued new guidance on advertising and promotion. MHRA – Advertising and Promotion Guidance Following Agreement of the Windsor Framework
AESGP Webinar – Online Trade of Consumer Healthcare Products AESGP is hosting a webinar, 'Online Trade of Consumer Healthcare Products under the EU’s Digital Markets Act and Digital Services Act', on Tuesday 3 December, from 11.30 to 13.00 (GMT). AESGP Webinar – Online Trade of Consumer Healthcare Products
PAGB OTC Medicines Pack Design Workshop The next PAGB OTC Medicines Pack Design Workshop is taking place in-person on 4 December. PAGB OTC Medicines Pack Design Workshop
Life Sciences Innovative Manufacturing Fund (LSIMF): Expression of Interest The Life Sciences Innovative Manufacturing Fund (LSIMF) is open and will accept Expression of Interests (EOI) on a rolling basis. The government has committed up to £520 million for life sciences manufacturing, to help deliver on the government’s missions to kickstart economic growth and build an NHS fit for the future. Life Sciences Innovative Manufacturing Fund (LSIMF): Expression of Interest
European Shortages Monitoring Platform Training Webinar In preparation for the first launch of the European Shortages Monitoring Platform (ESMP) by the end of November 2024, EMA is organising training for relevant stakeholders to familiarise them with the system functionalities. European Shortages Monitoring Platform Training Webinar
Introducing eLearning with PAGB We have launched our new training platform, eLearning with PAGB, with new suite of on-demand training courses and free webinars. Introducing eLearning with PAGB
MHRA Marketing Authorisations Granted 1 to 14 October MHRA granted 1 OTC licence during 1-14 October 2024. MHRA Marketing Authorisations Granted 1 to 14 October
CMDh October 2024 Meeting – Report The Co-ordination group for Mutual recognition and Decentralised procedures – human (CMDh) has published the report from the CMDh meeting held on 15-16 October 2024. CMDh October 2024 Meeting – Report
MHRA Pipeline Intelligence Webinar Recording MHRA is requesting that current or potential medicines MAHs provide information on planned or potential future submissions to MHRA. The recording of the webinar on this new forecasting process, which took place in September 2024, has been published. MHRA Pipeline Intelligence Webinar Recording
HPRA Updated Q&A on Windsor Framework – Joint Labels Between IE/UK The Health Products Regulatory Authority (HPRA) has published an updated Q&A document relating to the impact of the Windsor Framework on the regulation of human medicines. The document is based on questions HPRA has received from companies and includes updated information on joint labels between IE/UK. HPRA Updated Q&A on Windsor Framework – Joint Labels Between IE/UK
MHRA Letter on Windsor Framework Preparedness MHRA has shared a reminder of the continued preparations required ahead of the implementation of the Windsor Framework on 1 January 2025. MHRA Letter on Windsor Framework Preparedness
MHRA Performance Data for Assessment of New Marketing Authorisations, Variations and Clinical Trial Authorisation The MHRA performance metrics for new marketing authorisation applications, variations, and clinical trial authorisation assessment have been updated. MHRA Performance Data for Assessment of New Marketing Authorisations, Variations and Clinical Trial Authorisation
